Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies

In recent years, the prevalence of metabolic-associated fatty liver disease (MAFLD) has reached pandemic proportions as a leading cause of liver fibrosis worldwide. However, the stage of liver fibrosis is associated with an increased risk of severe liver-related and cardiovascular events and is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Qingfu, Bao, Haolin, Wang, Jiangang, Shi, Wujiang, Zou, Xinlei, Sheng, Jialin, Gao, Jianjun, Guan, Canghai, Xia, Haoming, Li, Jinglin, Kang, Pengcheng, Xu, Yi, Cui, Yunfu, Zhong, Xiangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157161/
https://www.ncbi.nlm.nih.gov/pubmed/37153080
http://dx.doi.org/10.3389/fmed.2023.1120621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157161/
https://www.ncbi.nlm.nih.gov/pubmed/37153080
http://dx.doi.org/10.3389/fmed.2023.1120621

Ejemplares similares